- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01803659
Effect of Small Daily Doses of B-carotene on Breast Milk Retinol
June 10, 2015 updated by: University of California, Davis
Effect of Small Daily Doses of B-carotene or Vitamin A on Breast Milk Retinol Concentration in Lactating Filipino Women.
The purpose of this pilot study is to determine whether breast milk retinol concentration increases in response to daily supplementation with small amounts of vitamin A (~600 ug RAE/d), as either a b-carotene or retinyl palmitate, 6 d/week for 3 weeks.
A secondary purpose is to evaluate sampling methods for collecting breast milk samples in a community setting.
The results of this pilot study will allow us to determine whether milk retinol is a useful indicator for evaluating the impact of food-based interventions on the vitamin A status of lactating women.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
85
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Davis, California, United States, 95616
- University of California, Davis
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- lactating women breastfeeding a single infant 4-12 months of age
Exclusion Criteria:
- chronic disease
- breastfeeding more than one infant
- severe anemia
- signs or symptoms of vitamin A deficiency
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: b-carotene
600 ug RAE/d as b-carotene, 6 d/wk for 3 weeks
|
|
|
ACTIVE_COMPARATOR: retinyl palmitate
600 ug retinol equivalent/d, 6 d/wk for 3 weeks
|
|
|
PLACEBO_COMPARATOR: placebo (corn oil)
0 ug RAE/d as corn oil
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
breast milk retinol concentration
Time Frame: 3 weeks
|
breast milk retinol concentration is measured at baseline and after 3 weeks of supplementation with 600 ug RAE/d (as either b-carotene or retinyl palmitate) or 0 ug RAE/d
|
3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
plasma retinol concentration
Time Frame: 3 weeks
|
plasma retinol concentration is measured at baseline and after 3 weeks of supplementation with 600 ug RAE/d (as either b-carotene or retinyl palmitate) or 0 ug RAE/d
|
3 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2013
Primary Completion (ACTUAL)
June 1, 2013
Study Completion (ACTUAL)
June 1, 2013
Study Registration Dates
First Submitted
February 28, 2013
First Submitted That Met QC Criteria
March 1, 2013
First Posted (ESTIMATE)
March 4, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
June 11, 2015
Last Update Submitted That Met QC Criteria
June 10, 2015
Last Verified
June 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 6195-2012-01-00-HKI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitamin A Status
-
University of California, DavisBill and Melinda Gates Foundation; Penn State University; Newcastle University; Helen Keller International and other collaboratorsCompletedVitamin A StatusPhilippines
-
Institute of Nutrition of Central America and PanamaBill and Melinda Gates Foundation; Newcastle University; International Atomic...Completed
-
Prince of Songkla UniversityUnknown
-
Tufts UniversityNutricia Research Fundation; National University of Science and Technology,...Completed
-
University of Wisconsin, MadisonCompletedVitamin A Status With Maize Feeding
-
North-West University, South AfricaMedical Research Council, South Africa; National Research Foundation of South... and other collaboratorsCompletedMalnutrition | Vitamin A Status | Iron Status | Zinc StatusSouth Africa
-
National Food Technology Research Centre, BotswanaNetherlands: Ministry of Health, Welfare and Sports; UNICEF; University of BotswanaUnknownAssessment of Vitamin A Status of Children
-
Ohio State UniversityRecruitingAdequate Vitamin C Status | Inadequate Vitamin C StatusUnited States
-
University of UlsterNorthern Ireland Executive; HSC Public Health AgencyCompletedVitamin D Status | Vitamin D ConcentrationUnited Kingdom
-
University of UlsterAgri-Food and Biosciences Institute; Foodovation North West Regional College; Kenedy Bacon and other collaboratorsEnrolling by invitationVitamin D Status | Vitamin D Biofortification | Vitamin D FortificationUnited Kingdom
Clinical Trials on placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AkesoNot yet recruitingAtopic DermatitisChina
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States